BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36098476)

  • 21. Risk of abducens nerve palsy following COVID-19 vaccination.
    Chauhan MZ; Eleiwa TK; Abdelnaem S; Kwok A; Hunter DG; Phillips PH; Sallam AB; Elhusseiny AM
    J AAPOS; 2024 Apr; 28(2):103867. PubMed ID: 38458601
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patient attitudes toward influenza and tetanus, diphtheria and acellular pertussis vaccination in pregnancy.
    Strassberg ER; Power M; Schulkin J; Stark LM; Mackeen AD; Murtough KL; Paglia MJ
    Vaccine; 2018 Jul; 36(30):4548-4554. PubMed ID: 29907484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenicity and safety of a second booster dose of an acellular pertussis vaccine combined with reduced antigen content diphtheria-tetanus toxoids 10 years after a first booster in adolescence: An open, phase III, non-randomized, multi-center study.
    Kovac M; Kostanyan L; Mesaros N; Kuriyakose S; Varman M
    Hum Vaccin Immunother; 2018; 14(8):1977-1986. PubMed ID: 29630439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influenza and Tetanus, Diphtheria, and Acellular Pertussis Vaccination Coverage During Pregnancy: Pregnancy Risk Assessment Monitoring System, 2020.
    Kortsmit K; Oduyebo T; Simeone RM; Kahn KE; Razzaghi H; Galang RR; Ellington S; Ruffo N; Barfield WD; Warner L; Cox S
    Public Health Rep; 2024; 139(2):218-229. PubMed ID: 37386826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of maternal diphtheria-tetanus-acellular pertussis vaccination on pertussis booster immune responses in toddlers: Follow-up of a randomized trial.
    Martinón-Torres F; Halperin SA; Nolan T; Tapiéro B; Perrett KP; de la Cueva IS; García-Sicilia J; Stranak Z; Vanderkooi OG; Kosina P; Rumlarova S; Virta M; Arribas JMM; Miranda-Valdivieso M; Novas BA; Bozensky J; Ortega MJC; Amador JTR; Baca M; Palomino EE; Zuccotti GV; Janota J; Marchisio PG; Kostanyan L; Meyer N; Ceregido MA; Cheuvart B; Kuriyakose SO; Mesaros N
    Vaccine; 2021 Mar; 39(11):1598-1608. PubMed ID: 33612341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine.
    Zepp F; Knuf M; Habermehl P; Mannhardt-Laakmann W; Howe B; Friedland LR
    J Pediatr; 2006 Nov; 149(5):603-610. PubMed ID: 17095328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An analysis of factors associated with influenza, pneumoccocal, Tdap, and herpes zoster vaccine uptake in the US adult population and corresponding inter-state variability.
    La EM; Trantham L; Kurosky SK; Odom D; Aris E; Hogea C
    Hum Vaccin Immunother; 2018 Feb; 14(2):430-441. PubMed ID: 29194019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characteristics and perceptions associated with COVID-19 vaccination hesitancy among pregnant and postpartum individuals: A cross-sectional study.
    Kiefer MK; Mehl R; Costantine MM; Johnson A; Cohen J; Summerfield TL; Landon MB; Rood KM; Venkatesh KK
    BJOG; 2022 Jul; 129(8):1342-1351. PubMed ID: 35104382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influenza and tetanus, diphtheria, and acellular pertussis vaccinations during pregnancy.
    Fortner KB; Kuller JA; Rhee EJ; Edwards KM
    Obstet Gynecol Surv; 2012 Apr; 67(4):251-7. PubMed ID: 22495061
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Tdap upon antibody response to meningococcal polysaccharide when administered before, with or after the quadrivalent meningococcal TT-conjugate vaccine (coadministered with the 13-valent pneumococcal CRM197-conjugate vaccine) in adult Hajj pilgrims: A randomised controlled trial.
    Tashani M; Alfelali M; Barasheed O; Alqahtani AS; Heron L; Wong M; Rashid H; Findlow H; Borrow R; Booy R
    Vaccine; 2018 Jul; 36(29):4375-4382. PubMed ID: 29880243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults.
    Sirivichayakul C; Chanthavanich P; Limkittikul K; Siegrist CA; Wijagkanalan W; Chinwangso P; Petre J; Hong Thai P; Chauhan M; Viviani S
    Hum Vaccin Immunother; 2017 Jan; 13(1):136-143. PubMed ID: 27686283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The need for pertussis vaccination among older adults and high-risk groups: a perspective from advanced economies of the Asia Pacific region.
    Hoe Nam L; Chiu CH; Heo JY; Ip M; Jung KS; Menzies R; Pearce R; Buchy P; Chen J; Nissen M; Oh KB
    Expert Rev Vaccines; 2021 Dec; 20(12):1603-1617. PubMed ID: 34734556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine in the USA.
    Pool V; Tomovici A; Johnson DR; Greenberg DP; Decker MD
    Vaccine; 2018 Apr; 36(17):2282-2287. PubMed ID: 29573876
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand.
    Koepke R; Eickhoff JC; Ayele RA; Petit AB; Schauer SL; Hopfensperger DJ; Conway JH; Davis JP
    J Infect Dis; 2014 Sep; 210(6):942-53. PubMed ID: 24903664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of pertussis, tetanus, and diphtheria among pregnant and postpartum women and their infants recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Murphy TV; Slade BA; Broder KR; Kretsinger K; Tiwari T; Joyce PM; Iskander JK; Brown K; Moran JS;
    MMWR Recomm Rep; 2008 May; 57(RR-4):1-51. PubMed ID: 18509304
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Factors associated with Tdap vaccination receipt during pregnancy: a cross-sectional study.
    Wales DP; Khan S; Suresh D; Ata A; Morris B
    Public Health; 2020 Feb; 179():38-44. PubMed ID: 31726399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. COVID-19 Vaccination Recommendations and Practices for Women of Reproductive Age by Health Care Providers - Fall DocStyles Survey, United States, 2022.
    Meghani M; Salvesen Von Essen B; Zapata LB; Polen K; Galang RR; Razzaghi H; Meaney-Delman D; Waits G; Ellington S
    MMWR Morb Mortal Wkly Rep; 2023 Sep; 72(39):1045-1051. PubMed ID: 37768870
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantity and Quality of Antibodies After Acellular Versus Whole-cell Pertussis Vaccines in Infants Born to Mothers Who Received Tetanus, Diphtheria, and Acellular Pertussis Vaccine During Pregnancy: A Randomized Trial.
    Wanlapakorn N; Maertens K; Vongpunsawad S; Puenpa J; Tran TMP; Hens N; Van Damme P; Thiriard A; Raze D; Locht C; Poovorawan Y; Leuridan E
    Clin Infect Dis; 2020 Jun; 71(1):72-80. PubMed ID: 31418814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Tdap vaccine guidelines with vaccine uptake during pregnancy.
    DiTosto JD; Weiss RE; Yee LM; Badreldin N
    PLoS One; 2021; 16(7):e0254863. PubMed ID: 34280239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.